[Targeting apoptosis signaling pathways in cancer therapy].
Cheng
Liang
L
liang_cheng@yahoo.com
Wang
Xi
X
Zhang
Jie
J
Zhang
Shao-bo
SB
Zheng
Su-qin
SQ
Zheng
Jie
J
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017209:Apoptosis / Q000187:drug effects; D020169:Caspases / Q000378:metabolism* / Q000502:physiology; D004789:Enzyme Activation; D053222:Fas Ligand Protein / Q000378:metabolism; D006801:Humans; D016328:NF-kappa B / Q000378:metabolism; D009369:Neoplasms / Q000378:metabolism / Q000628:therapy*; D009389:Neovascularization, Pathologic; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000378:metabolism; D015398:Signal Transduction
D000970:Antineoplastic Agents; D053222:Fas Ligand Protein; D016328:NF-kappa B; D019253:Proto-Oncogene Proteins c-bcl-2; D020169:Caspases